Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)
- 1 July 2023
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 84 (1), 25-31
- https://doi.org/10.1016/j.eururo.2022.10.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Long-term Relative Survival after Diagnosis of Testicular Germ Cell TumorCancer Epidemiology, Biomarkers & Prevention, 2016
- Guidelines on Testicular Cancer: 2015 UpdateEuropean Urology, 2015
- Second cancer risk and mortality in men treated with radiotherapy for stage I seminomaBritish Journal of Cancer, 2013
- Complications associated with chemotherapy in testicular cancer managementNature Reviews Urology, 2011
- Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study GroupJournal of Clinical Oncology, 2011
- Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up StudyJournal of Clinical Oncology, 2010
- Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular CancerJournal of Clinical Oncology, 2007
- Identification and reduction of surgical error using simulationMinimally Invasive Therapy & Allied Technologies, 2005
- RETROPERITONEAL LYMPHADENECTOMY IN STAGING AND TREATMENT: The Development of Nerve-Sparing TechniquesUrologic Clinics of North America, 1998
- Relapses in Early-stage Testicular Seminoma: Radiation Therapy versus Retroperitoneal LymphadenectomyScandinavian Journal of Urology and Nephrology, 1997